Funded projects
– Second funding period “Mechanisms of cardiovascular complications on chronic
kidney disease”, SFB/TRR 219 (2022-2025); DFG-Project-ID 322900939
(Fliser/Jankowski)
– “treatCKD” Novel compounds for the treatment of chronic kidney disease
(01/2022-31/2024). Grant ID: ANR-21-CE18-0031 (Argiles, Schanstra)
– ERAPERmed dialysis “Patient-Reported Outcome, Biodata and Process
Data to Evaluate Dialysis Tolerability” (October 2020 to 2022)
– EU-ITN “STRATEGY-CKD” System omics to unravel the
gut-kidney axis in chronic kidney disease (2019-2024)
European Union’s Horizon 2020, Grant agreement ID: 860329
(Glorieux, Argiles, Burtey, Jankowski, Masereeuw, Mischak, Perna,
Vlahoua)
– ERA-Permed grant “Kidney Attack”, Multidimensional
stratification for treatment of acute kidney injury (2019-2022).
Grant agreement ID: U1048 (Ortiz, Mischak, Schanstra)
– EU-ITN “CaReSyAn (2018- 2021) CArdioREnal SYndrome ANalysis
European Union’s Horizon 2020, Grant agreement ID: 764474
(Argiles, Jankowski, Mischak, Schanstra, Stenvinkel, Vlahou)
– SFB TRR 219 (2018 – 2021) “Mechanisms of Cardiovascular
Complications in Chronic Kidney Disease”

– EU-ITN “INTRICARE” (2017-2020)
European Union’s Horizon 2020, Marie Skłodowska-Curie
Grant agreement ID: 722609
(Stenvinkel, Jankowski)
Closed project

